However, despite the fact that TNBC may not be particularly sensitive to CDK4/6 inhibitors, CDK4/6 protein is indispensable for the proliferation of Rb wild-type triple-negative breast cancer (Fassl et al., 2020). Here, CDK4 is linked to triple-negative breast carcinoma.